Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • State-of-the-art update: CDK4/6 inhibitors in ER+ metastatic breast cancer
    Journal Article

    Vasan, N.; Dickler, M. N.
    American Journal of Hematology/Oncology (2017)

    Fulltext@MSK | Save
  • Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance)
    Journal Article

    Bluethmann, S. M.; Alfano, C. M.; Clapp, J. D.; Luta, G.; Small, B. J.; Hurria, A.; Cohen, H. J.; Sugarman, S.; Muss, H. B.; Isaacs, C.; more...
    Breast Cancer Research and Treatment (2017)

    Fulltext@MSK | Save
  • The androgen receptor: Is it a promising target?
    Journal Article

    Gucalp, A.; Traina, T. A.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Does biomarker information impact breast cancer patients’ preferences and physician recommendation for adjuvant chemotherapy?
    Journal Article

    Partridge, A. H.; Sepucha, K.; O’Neill, A.; Miller, K. D.; Baker, E.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.; Schneider, B. P.
    Breast Cancer Research and Treatment (2017)

    Fulltext@MSK | Save
  • Kinetic-pharmacodynamic model of chemotherapy-induced peripheral neuropathy in patients with metastatic breast cancer treated with paclitaxel, nab-paclitaxel, or ixabepilone: CALGB 40502 (Alliance)
    Journal Article

    Mehrotra, S.; Sharma, M. R.; Gray, E.; Wu, K.; Barry, W. T.; Hudis, C.; Winer, E. P.; Lyss, A. P.; Toppmeyer, D. L.; Moreno-Aspitia, A.; more...
    AAPS Journal (2017)

    Fulltext@MSK | Save
  • An approach to suppress the evolution of resistance in BRAF(V600E)-mutant cancer
    Journal Article

    Xue, Y.; Martelotto, L.; Baslan, T.; Vides, A.; Solomon, M.; Mai, T. T.; Chaudhary, N.; Riely, G. J.; Li, B. T.; Scott, K.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Anthracyclines in early breast cancer: The ABC trials - USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
    Journal Article

    Blum, J. L.; Flynn, P. J.; Yothers, G.; Asmar, L.; Geyer, C. E., Jr.; Jacobs, S. A.; Robert, N. J.; Hopkins, J. O.; O’Shaughnessy, J. A.; Dang, C. T.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Journal Article

    Mandelker, D.; Zhang, L.; Kemel, Y.; Stadler, Z. K.; Joseph, V.; Zehir, A.; Pradhan, N.; Arnold, A.; Walsh, M. F.; Li, Y.; more...
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save
  • MONARCH 1, a phase II study of abemaciclib, a CDK4 and CDK6 inhibitor, as a single agent, in patients with refractory HR(+)/HER2(-) metastatic breast cancer
    Journal Article

    Dickler, M. N.; Tolaney, S. M.; Rugo, H. S.; Cortés, J.; Diéras, V.; Patt, D.; Wildiers, H.; Hudis, C. A.; O'Shaughnessy, J.; Zamora, E.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • The microbial flora of taxane therapy-associated nail disease in cancer patients
    Meeting Abstract

    Virgen, C. A.; Belum, V. R.; Kamboj, M.; Goldfarb, S. B.; Blinder, V. S.; Gucalp, A.; Lacouture, M. E.
    Journal of Investigative Dermatology (2017)

    Fulltext@MSK | Save